Novel Preclinical Drug Could Have Potential to Combat Depression, Brain Injury, and Cognitive Disorders
Novel Preclinical Drug Could Have Potential to Combat Depression, Brain Injury, and Cognitive Disorders
ElectrophysiologyFeatured·May 30, 2013·4 min readKetamine Cousin Rapidly Lifts Depression Without Side EffectsA new study funded by the NIMH suggests GLYX-13, a molecular cousin to ketamine, induces similar antidepressant results without the negative side effects of the well known street drug.Read More
Novel Preclinical Drug Could Have Potential to Combat Depression, Brain Injury, and Cognitive Disorders
